AAAAAA

   
Results: 1-25 | 26-50 | 51-60
Results: 1-25/60
POSTMARKETING SURVEILLANCE OF THE SAFETY OF CIMETIDINE - 15-YEAR MORTALITY REPORT
Authors: BERESFORD J COLINJONES DG FLIND AC LANGMAN MJS LAWSON DH LOGAN RFA PATERSON KR VESSEY MP
Citation: J. Beresford et al., POSTMARKETING SURVEILLANCE OF THE SAFETY OF CIMETIDINE - 15-YEAR MORTALITY REPORT, Pharmacoepidemiology and drug safety, 7(5), 1998, pp. 319-322
VARYING EFFICACY OF HELICOBACTER-PYLORI ERADICATION REGIMENS - COST-EFFECTIVENESS STUDY USING A DECISION-ANALYSIS MODEL
Authors: DUGGAN AE TOLLEY K HAWKEY CJ LOGAN RFA
Citation: Ae. Duggan et al., VARYING EFFICACY OF HELICOBACTER-PYLORI ERADICATION REGIMENS - COST-EFFECTIVENESS STUDY USING A DECISION-ANALYSIS MODEL, BMJ. British medical journal, 316(7145), 1998, pp. 1648-1654
WHO DIES FROM HERNIA
Authors: REAVELEY AM NGUYENVANTAM JS LOGAN RFA
Citation: Am. Reaveley et al., WHO DIES FROM HERNIA, Journal of epidemiology and community health, 52(8), 1998, pp. 532-533
APPENDECTOMY, CHILDHOOD HYGIENE, HELICOBACTER-PYLORI STATUS, AND RISKOF INFLAMMATORY BOWEL-DISEASE - A CASE-CONTROL STUDY
Authors: DUGGAN AE USMANI I NEAL KR LOGAN RFA
Citation: Ae. Duggan et al., APPENDECTOMY, CHILDHOOD HYGIENE, HELICOBACTER-PYLORI STATUS, AND RISKOF INFLAMMATORY BOWEL-DISEASE - A CASE-CONTROL STUDY, Gut, 43(4), 1998, pp. 494-498
INFLAMMATORY BOWEL-DISEASE INCIDENCE - UP, DOWN OR UNCHANGED
Authors: LOGAN RFA
Citation: Rfa. Logan, INFLAMMATORY BOWEL-DISEASE INCIDENCE - UP, DOWN OR UNCHANGED, Gut, 42(3), 1998, pp. 309-311
GOOD AND BAD HELICOBACTER - CAGA STATUS AND NSAID USE AS INDEPENDENT RISK-FACTORS FOR PEPTIC-ULCER BLEEDING
Authors: STACK WA HAWKEY GM ATHERTON JC PEARSON G EVERITT S FIELDING K LOGAN RFA HAWKEY CJ
Citation: Wa. Stack et al., GOOD AND BAD HELICOBACTER - CAGA STATUS AND NSAID USE AS INDEPENDENT RISK-FACTORS FOR PEPTIC-ULCER BLEEDING, Gut, 42, 1998, pp. 11-11
RATIONAL PRESCRIBING OF PROPHYLAXIS IN PATIENTS TAKING NSAIDS
Authors: SEAGER JM PO ALW LOGAN RFA HAWKEY CJ
Citation: Jm. Seager et al., RATIONAL PRESCRIBING OF PROPHYLAXIS IN PATIENTS TAKING NSAIDS, Gut, 42, 1998, pp. 274-274
BLOOD IN THE STOMACH AS A SURROGATE FOR CLINICAL END-POINTS IN GI BLEEDING TRIALS
Authors: HAWKEY GM STACK WA COLE AT LONG RG LOGAN RFA HAWKEY CJ
Citation: Gm. Hawkey et al., BLOOD IN THE STOMACH AS A SURROGATE FOR CLINICAL END-POINTS IN GI BLEEDING TRIALS, Gut, 42, 1998, pp. 276-276
HOW ACCURATE IS NEAR PATIENT H. PYLORI TESTING IN PRIMARY-CARE
Authors: DUGGAN A ELLIOTT C LOGAN RFA
Citation: A. Duggan et al., HOW ACCURATE IS NEAR PATIENT H. PYLORI TESTING IN PRIMARY-CARE, Gut, 42, 1998, pp. 310-310
DOES NEAR PATIENT HELICOBACTER-PYLORI TESTING IN PRIMARY-CARE REDUCE REFERRAL FOR ENDOSCOPY - RESULTS FROM A RANDOMIZED TRIAL
Authors: DUGGAN A ELLIOTT C LOGAN RPH HAWKEY C LOGAN RFA
Citation: A. Duggan et al., DOES NEAR PATIENT HELICOBACTER-PYLORI TESTING IN PRIMARY-CARE REDUCE REFERRAL FOR ENDOSCOPY - RESULTS FROM A RANDOMIZED TRIAL, Gut, 42, 1998, pp. 325-325
HOW ACCURATE IS NEAR PATIENT HELICOBACTER-PYLORI TESTING IN PRIMARY-CARE
Authors: DUGGAN A ELLIOTT C LOGAN RFA
Citation: A. Duggan et al., HOW ACCURATE IS NEAR PATIENT HELICOBACTER-PYLORI TESTING IN PRIMARY-CARE, Gut, 42, 1998, pp. 326-326
DOES NEAR PATIENT HELICOBACTER-PYLORI TESTING IN PRIMARY-CARE REDUCE REFERRAL FOR ENDOSCOPY - RESULTS FROM A RANDOMIZED TRIAL
Authors: DUGGAN A ELLIOTT C LOGAN RPH HAWKEY C LOGAN RFA
Citation: A. Duggan et al., DOES NEAR PATIENT HELICOBACTER-PYLORI TESTING IN PRIMARY-CARE REDUCE REFERRAL FOR ENDOSCOPY - RESULTS FROM A RANDOMIZED TRIAL, Gastroenterology, 114(4), 1998, pp. 451-451
BLOOD IN THE STOMACH AS A SURROGATE FOR CLINICAL END-POINTS IN GI BLEEDING TRIALS
Authors: HAWKEY GM STACK WA COLE AT LONG RG LOGAN RFA HAWKEY CJ
Citation: Gm. Hawkey et al., BLOOD IN THE STOMACH AS A SURROGATE FOR CLINICAL END-POINTS IN GI BLEEDING TRIALS, Gastroenterology, 114(4), 1998, pp. 598-598
NSAIDS AND CAGA POSITIVE HELICOBACTER-PYLORI BUT NOT CAGA NEGATIVE HELICOBACTER-PYLORI AS INDEPENDENT RISK-FACTORS FOR BLEEDING PEPTIC-ULCERS
Authors: STACK WA HAWKEY GM ATHERTON JC PEARSON G EVERITT S FIELDING K LOGAN RFA HAWKEY CJ
Citation: Wa. Stack et al., NSAIDS AND CAGA POSITIVE HELICOBACTER-PYLORI BUT NOT CAGA NEGATIVE HELICOBACTER-PYLORI AS INDEPENDENT RISK-FACTORS FOR BLEEDING PEPTIC-ULCERS, Gastroenterology, 114(4), 1998, pp. 1206-1206
LINKAGE ANALYSIS OF CANDIDATE REGIONS FOR CELIAC-DISEASE GENES
Authors: HOULSTON RS TOMLINSON IPM FORD D SEAL S MAROSSY AM FERGUSON A HOLMES GKT HOSIE KB HOWDLE PD JEWELL DP GODKIN A KERR GD KUMAR P LOGAN RFA LOVE AHG JOHNSTON S MARSH MN MITTON S ODONOGHUE D ROBERTS A WALKERSMITH JA STRATTON MF
Citation: Rs. Houlston et al., LINKAGE ANALYSIS OF CANDIDATE REGIONS FOR CELIAC-DISEASE GENES, Human molecular genetics, 6(8), 1997, pp. 1335-1339
PRESCRIBING OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS IN GENERAL-PRACTICE - DETERMINANTS AND CONSEQUENCES
Authors: HAWKEY CJ CULLEN DJE GREENWOOD DC WILSON JV LOGAN RFA
Citation: Cj. Hawkey et al., PRESCRIBING OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS IN GENERAL-PRACTICE - DETERMINANTS AND CONSEQUENCES, Alimentary pharmacology & therapeutics, 11(2), 1997, pp. 293-298
INFLUENCING THE PRACTICE AND OUTCOME IN ACUTE UPPER GASTROINTESTINAL HEMORRHAGE
Authors: ROCKALL TA LOGAN RFA DEVLIN HB NORTHFIELD TC
Citation: Ta. Rockall et al., INFLUENCING THE PRACTICE AND OUTCOME IN ACUTE UPPER GASTROINTESTINAL HEMORRHAGE, Gut, 41(5), 1997, pp. 606-611
PEPTIC-ULCER BLEEDING IN THE ELDERLY - RELATIVE ROLES OF HELICOBACTER-PYLORI AND NONSTEROIDAL ANTIINFLAMMATORY DRUGS
Authors: CULLEN DJE HAWKEY GM GREENWOOD DC HUMPHREYS H SHEPHERD V LOGAN RFA HAWKEY CJ
Citation: Dje. Cullen et al., PEPTIC-ULCER BLEEDING IN THE ELDERLY - RELATIVE ROLES OF HELICOBACTER-PYLORI AND NONSTEROIDAL ANTIINFLAMMATORY DRUGS, Gut, 41(4), 1997, pp. 459-462
NON STEROIDAL ANTI INFLAMMATORY DRUGS, ASPIRIN AND HELICOBACTER-PYLORI AS RISK-FACTORS FOR BLEEDING PEPTIC-ULCERS
Authors: HAWKEY GM STACK WA PEARSON G EVERITT S LOGAN RFA HAWKEY CJ
Citation: Gm. Hawkey et al., NON STEROIDAL ANTI INFLAMMATORY DRUGS, ASPIRIN AND HELICOBACTER-PYLORI AS RISK-FACTORS FOR BLEEDING PEPTIC-ULCERS, Gut, 41, 1997, pp. 5-5
INCIDENCE OF IBD HAS INCREASED BUT WHAT ELSE HAVE DESCRIPTIVE STUDIESSHOWN
Authors: LOGAN RFA
Citation: Rfa. Logan, INCIDENCE OF IBD HAS INCREASED BUT WHAT ELSE HAVE DESCRIPTIVE STUDIESSHOWN, Gut, 41, 1997, pp. 36-36
DO CELIACS SUFFER MORE FRACTURES THAN THE GENERAL-POPULATION - A POPULATION-BASED SURVEY OF THE FRACTURE EXPERIENCE OF OLDER CELIACS
Authors: THOMASON K COUPLAND CA HOLMES GKT LOGAN RFA
Citation: K. Thomason et al., DO CELIACS SUFFER MORE FRACTURES THAN THE GENERAL-POPULATION - A POPULATION-BASED SURVEY OF THE FRACTURE EXPERIENCE OF OLDER CELIACS, Gut, 41, 1997, pp. 72-72
HOW IMPORTANT IS ANTIBIOTIC REGIMEN EFFICACY IN DETERMINING COST-EFFECTIVENESS OF HP ERADICATION IN PROVEN DU DISEASE
Authors: DUGGAN AE TOLLEY K LOGAN RFA
Citation: Ae. Duggan et al., HOW IMPORTANT IS ANTIBIOTIC REGIMEN EFFICACY IN DETERMINING COST-EFFECTIVENESS OF HP ERADICATION IN PROVEN DU DISEASE, Gut, 41, 1997, pp. 166-166
CIGARETTE-SMOKING AND CELIAC-DISEASE - A POPULATION-BASED STUDY
Authors: THOMASON K COUPLAND CA HOLMES GKT LOGAN RFA
Citation: K. Thomason et al., CIGARETTE-SMOKING AND CELIAC-DISEASE - A POPULATION-BASED STUDY, Gut, 41, 1997, pp. 218-218
HIGH PREVALENCE OF UNDETECTED INFLAMMATORY BOWEL-DISEASE (IBD) - DATAFROM THE NOTTINGHAM FECAL OCCULT BLOOD (FOE) SCREENING TRIAL
Authors: HOWARTH GF ROBINSON MHE JENKINS D HARDCASTLE JD LOGAN RFA
Citation: Gf. Howarth et al., HIGH PREVALENCE OF UNDETECTED INFLAMMATORY BOWEL-DISEASE (IBD) - DATAFROM THE NOTTINGHAM FECAL OCCULT BLOOD (FOE) SCREENING TRIAL, Gut, 40, 1997, pp. 83-83
HELICOBACTER-PYLORI ERADICATION IN DUODENAL-ULCER DISEASE - WHAT DETERMINES COST-EFFECTIVENESS
Authors: DUGGAN AE TOLLEY K HAWKEY CJ LOGAN RFA
Citation: Ae. Duggan et al., HELICOBACTER-PYLORI ERADICATION IN DUODENAL-ULCER DISEASE - WHAT DETERMINES COST-EFFECTIVENESS, Gut, 40, 1997, pp. 229-229
Risultati: 1-25 | 26-50 | 51-60